News

Using CORRONA Registry Data to Treat Rheumatic Diseases


 

The Consortium of Rheumatology Researchers of North America (or CORRONA) primarily manages a database, and data analysis, of rheumatic diseases. Dr. Joel Kremer, CORRONA president and CEO, offered an update on the group's work at the 2012 Perspectives of Rheumatic Diseases in Newport Beach, Calif., held by Global Academy for Medical Education. GAME and this news organization are owned by Frontline Medical Communications.

Recommended Reading

New Stripped-Down Rituximab Retreatment Regimen May Be Effective
MDedge Rheumatology
GnRH Antagonist Improves Rheumatoid Arthritis
MDedge Rheumatology
Tofacitinib Effective as Monotherapy or Adjunct for Refractory RA
MDedge Rheumatology
Enthesis-Related Arthritis Has Two Faces
MDedge Rheumatology
Anti-TNF Use Linked to Cardiovascular-Disease Drop in RA
MDedge Rheumatology
Adalimumab Plus Methotrexate Reduced Joint Damage in RA
MDedge Rheumatology
Resistant Hypothyroidism? Consider Adding Liothyronine
MDedge Rheumatology
Biologic Agents for RA Don't Appear to Raise Malignancy Risk
MDedge Rheumatology
Psoriasis Severity Linked to Tonsil Size
MDedge Rheumatology
Rifampin Combinations May Protect Against C. difficile Colitis
MDedge Rheumatology